Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is N/A as of Tuesday, October 6, 2026.
ENTERPRISE VALUE (EV)
N/A
Electra Therapeutics Inc.
Market Cap
$201.52M
Enterprise Value (EV)
N/A
Market Cap
$214.63M
Enterprise Value (EV)
$206.86M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Electra Therapeutics Inc. (ETRA) | $201.52M | N/A |
| Pro-Dex, Inc. (PDEX)vs › | $206.04M | $215.95M |
| RxSight, Inc. (RXST)vs › | $194.56M | $191.79M |
| Sionna Therapeutics, Inc. (SION)vs › | $209.12M | $153.87M |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $209.49M | $125.74M |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $191.04M | $184.70M |
| Compugen Ltd. (CGEN)vs › | $213.22M | $205.96M |
| Prelude Therapeutics Incorporated (PRLD)vs › | $214.21M | $205.53M |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $214.63M | $206.86M |
| Niagen Bioscience Inc (NAGE)vs › | $214.64M | $150.23M |
Market Cap
$201.52M
Total Debt
N/A
Cash
N/A
Enterprise Value
N/A
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
